Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Compounded GLP-1 provider

Mochi Health

Semaglutide + Tirzepatide
Mochi Health compounded semaglutide + tirzepatide injection vial — editorial illustration
Provider Review · 73/100 · Updated 2026-05-08

Mochi Health Review

NP-led compounded semaglutide model. Two pillars met (clinical protocol, follow-up cadence). Pricing is competitive in the compounded segment.

#9 of 1073/100$209/mo
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Overview

NP-led compounded semaglutide model. Two pillars met (clinical protocol, follow-up cadence). Pricing is competitive in the compounded segment.

Mochi Health at a glance

Editorial rank
#9 of 10
Score
73/100 · 3.6/5 stars
Pillars met
2 of 6
Pricing
$209/mo
Pharmacy model
503A compounded
Clinical model
Compounded, NP-led

Six-pillar scoring

Mochi Health meets 2 of 6 v3.0 transparency pillars. Two pillars met indicates a stronger profile but still gaps versus the rubric leaders.

Pricing

$209/mo. Verify final pricing directly with the provider before purchasing — prices may change.

Trade-offs to know

How to evaluate Mochi Health

If you're considering Mochi Health, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.

Visit Mochi Health →

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.